The U.S.-India Business Council's Life Sciences Executive Committee actively advocates for building a stronger regulatory framework for pharmaceuticals, medical devices, and related healthcare products in India by engaging with government and other stakeholders to address key industry concerns. The committee has been instrumental in building a better understanding of the changing regulatory landscape, while advocating for the creation of transparent guidelines across the sector. The committee engages with both U.S. and Indian policymakers to promote the expansion of health insurance coverage, educate the community on the importance of intellectual property, and reinforce the message that human safety trumps cost.
The opportunity for growth in both the Indian and U.S. market is great if a proper policy environment can be established and maintained. Indian companies are proving their credentials, thus establishing a global presence. Cooperation between the U.S. and Indian life sciences industries requires the development of a policy environment that will expand access and support business opportunities in both countries.
USIBC's Executive Committees: